This year's Rare Disease Day, February 29, served as a momentous occasion to celebrate the extraordinary journeys of rare disease patients and their devoted caregivers. Having established a strong presence in the Vietnamese market over many years, Takeda holds steadfast in its commitment to bolstering the wellbeing of the Vietnamese people, especially those afflicted by rare diseases. Than Trong Son, head of Medical Affairs, Takeda Vietnam, delves into Takeda's tireless endeavours and commitment to supporting patients afflicted by rare diseases in the country.

On September 28, Takeda Pharmaceuticals (Asia-Pacific) Pte., Ltd. (Takeda), in collaboration with The Pasteur Institute in Ho Chi Minh City, held the conference Orientations and Solutions to Enhance Dengue Haemorrhagic Fever Prevention Effectiveness in Vietnam, attracting many top-notch experts from the healthcare industry.

The Pasteur Institute in Ho Chi Minh City joined hands with Takeda Vietnam to host a workshop on Innovating and enhancing the effectiveness of dengue prevention and control for public health on September 23.

Takeda Vietnam has prevailed over thousands of organisations to win the Best Workplace in Asia 2022 award by Great Place to Work, the global authority on workplace culture.

Takeda Vietnam was recognised as one of Vietnam’s best workplaces in 2022 by Great Place to Work® ASEAN & ANZ, the global organisation on workplace culture.

Takeda Vietnam is demonstrating its commitment to protecting the planet through the planting of more than 500 trees in Can Gio Biosphere Reserve, located about 50km from Ho Chi Minh City.

Over the past few years, Vietnam has placed more focus on rare diseases and enhanced rare disease capabilities in diagnosis, treatment, and management guidelines for some rare diseases. To advance this progress, the Vietnamese Ministry of Health has explored collaborating in public-private partnerships with various stakeholders such as pharmaceutical companies. Katharina Geppert, country manager of Takeda Vietnam, talked with VIR about their contributions to rare diseases in Vietnam.

Takeda and stakeholders have announced the launch of a programme for establishing diagnostic methods, strengthening treatment and developing guidelines for hereditary angioedema (HAE) in Vietnam.

The Japanese Embassy in Vietnam will organize calligraphy demonstration and workshop entitled “The Power of Calligraphy” from Takeda Souun at Temple of Literature in Hanoi at 10 a.m. on Saturday.